NELLCOR PURITAN BENNETT IRELAND UNLIMITED COMPANY
Location
Founded
1989-05-15
Website
Risk Signals
8565 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Surgical and Medical Instruments and Apparatus), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about NELLCOR PURITAN BENNETT IRELAND UNLIMITED COMPANY
Live alerts from global media, monitored by Business Radar
2024-02-16 (massdevice.com)
High-ranking official in FDA's CDRH plans to retire
Dr. William Maisel, Director of the OPEQ for the FDA Center for Devices and Radiological Health (CDRH) plans to retire this year.
Read more
2021-12-10 (commercialappeal.com)
Medtronic, CEVA to invest $250 million in Memphis creating 265 new jobs
Medtronic is likely moving its Memphis operations to Airways Boulevard. Part of the facility will be sublet to CEVA Logistics, which will create new jobs.
Read more
2019-04-22 (massdevice.com)
Philips Medical Systems accuses ex-enginer of pilfering trade secrets
A former engineer at Philips Medical Systems in Illinois allegedly transferred confidential trade secrets and then tried to destroy the evidence, the company said in a lawsuit filed last week.
Read more
2018-09-24 (1limburg.nl)
New Medtronic distribution center creates 300 jobs
Medtronic's new distribution center in Heerlen has created 300 new jobs.
Read more
2011-02-22 (fiercebiotech.com)
Medtronic to cut up to 2,000 jobs
Medical device giant Medtronic is planning to cut between 1,500 and 2,000 jobs. The announcement came as the company reported its FY 2011 Q3 financial results, during which it cut its full-year | Medical device giant Medtronic is planning to cut between 1,500 and 2,000 jobs.
Read more
2007-04-16 (informa.com)
Medtronic reorganization
Firm combines its vascular and cardiac surgery businesses on April 11 to support "the convergence of cardiovascular specialties focused on applying both surgical and minimally invasive approaches to patient care," says Scott Ward, head of the new business. The new entity, Medtronic CardioVascular,
Read more
(biospace.com)
Layoff Tracker: Idorsia Pharmaceuticals Could Cut 270 Employees Globally
2023 was a tough year for the biopharma industry, with several companies downsizing and restructuring their workforces to stay afloat. There are signs of recovery, as mergers and acquisitions picked up across the pharmaceutical and life sciences industry in the latter part of 2023 and have continued their upswing into 2024. Will the job market follow suit?
Read more